Vaccine-associated adverse events (VAAEs), including feline injection-site sarcomas
(FISSs), occur only rarely but can be severe. Understanding potential VAAEs is an important …

Immune-mediated hemolytic anemia (IMHA) is a common type of anemia in dogs and cats
that results from a type II hypersensitivity reaction. The disease is most common in middle …

Immune‐mediated hemolytic anemia (IMHA) is an important cause of morbidity and mortality
in dogs. IMHA also occurs in cats, although less commonly. IMHA is considered secondary …

Medical records of 72 dogs diagnosed with immune‐mediated hemolytic anemia (IMHA)
were reviewed to find risk factors for the disease, for mortality, and for thromboembolism …

Objective—To evaluate prognostic factors, survival, and treatment protocols for immune-
mediated hemolytic anemia (IMHA) in dogs. Design—Retrospective study. Animals—151 …

Objective—To assess whether serum canine parvovirus (CPV) and canine distemper virus
(CDV) antibody titers can be used to determine revaccination protocols in healthy dogs …

Hemostatic parameters were prospectively measured in 20 dogs with primary immune-
mediated hemolytic anemia. Eight of 20 dogs had received prior treatment with prednisone …

Survival times and mortality rates in dogs with idiopathic immune-mediated hemolytic
anemia (IMHA) have been infrequently reported in the literature. This study evaluates …

Background: Canine idiopathic immune‐mediated hemolytic anemia (IMHA) is associated
with a high mortality, especially in the 1st 2 weeks after diagnosis despite treatment …

Objective—To determine whether vaccinated dogs either remained seropositive or
responded serologically to revaccination for 5 key viral antigens after extended periods …